Marta Capelán
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- COVID-19 and healthcare impacts
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Lung Cancer Research Studies 2
- Co-authors
- Kamal S. Saini (2 shared papers)Evandro de Azambuja (4 shared papers)Christos Sotiriou (1 shared paper)Ivana Babič Božović (1 shared paper)Lina Pugliano (3 shared papers)Sherene Loi (1 shared paper)Martine Piccart (2 shared papers)Hazel Lote (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)Clinical & Translational Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomSpainBelgium
In The Last Decade
Marta Capelán
20 papers receiving 317 citations
Peers
Comparison fields: 5 of 66
- Oncology 202
- Radiology, Nuclear Medicine and Imaging 81
- Cancer Research 35
- Genetics 23
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by Marta Capelán
This map shows the geographic impact of Marta Capelán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Capelán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Capelán more than expected).
Fields of papers citing papers by Marta Capelán
This network shows the impact of papers produced by Marta Capelán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Capelán. The network helps show where Marta Capelán may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Capelán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 124 | |
| 2 | 2017 | 37 | |
| 3 | 2015 | 28 | |
| 4 | 2015 | 27 | |
| 5 | 2016 | 24 | |
| 6 | 2020 | 21 | |
| 7 | 2007 | 16 | |
| 8 | 2016 | 11 | |
| 9 | 2017 | 6 | |
| 10 | 2013 | 5 | |
| 11 | 2017 | 4 | |
| 12 | 2014 | 4 | |
| 13 | 2008 | 3 | |
| 14 | 2013 | 3 | |
| 15 | 2017 | 2 | |
| 16 | 2012 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2014 | 1 |
About Marta Capelán
Marta Capelán is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 321 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Lung Cancer Research Studies (2 papers), Microtubule and mitosis dynamics (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (202 citations), Radiology, Nuclear Medicine and Imaging (81 citations), Cancer Research (35 citations), Genetics (23 citations) and Pulmonary and Respiratory Medicine (66 citations). Marta Capelán has collaborated with scholars based in United Kingdom, Spain and Belgium. Frequent co-authors include Kamal S. Saini, Evandro de Azambuja, Christos Sotiriou, Ivana Babič Božović, Lina Pugliano, Sherene Loi, Martine Piccart, Hazel Lote, Udai Banerji and Adam Sharp. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, Clinical & Translational Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.